title: The cost effectiveness of mycophenolate mofetil in the first year after living related renal transplantation.
authors.affiliation: Department of Nephrology, Akdeniz University Medical School, Antalya, Turkey.
authors.forename: G
authors.initials: G
authors.lastname: Süleymanlar
authors.forename: M
authors.initials: M
authors.lastname: Tuncer
authors.forename: M
authors.initials: M
authors.lastname: Sarikaya
authors.forename: F
authors.initials: F
authors.lastname: Ersoy
authors.forename: S
authors.initials: S
authors.lastname: Aktan
authors.forename: G
authors.initials: G
authors.lastname: Yakupoğlu
authors.forename: T
authors.initials: T
authors.lastname: Karpuzoğlu
mesh_terms: D000328:Adult; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D004359:Drug Therapy, Combination; D005190:Family; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000191:economics / Q000276:immunology*; D007902:Length of Stay / Q000191:economics; D019520:Living Donors; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000191:economics* / Q000627:therapeutic use*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis; D014421:Turkey
chemical_list: D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid